JP2024519993A5 - - Google Patents

Info

Publication number
JP2024519993A5
JP2024519993A5 JP2023572661A JP2023572661A JP2024519993A5 JP 2024519993 A5 JP2024519993 A5 JP 2024519993A5 JP 2023572661 A JP2023572661 A JP 2023572661A JP 2023572661 A JP2023572661 A JP 2023572661A JP 2024519993 A5 JP2024519993 A5 JP 2024519993A5
Authority
JP
Japan
Prior art keywords
groups
group
homologous
heterocyclyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572661A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519993A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/095441 external-priority patent/WO2022247920A1/zh
Publication of JP2024519993A publication Critical patent/JP2024519993A/ja
Publication of JP2024519993A5 publication Critical patent/JP2024519993A5/ja
Pending legal-status Critical Current

Links

JP2023572661A 2021-05-27 2022-05-27 キノリンアミン系化合物、その調製方法及びその医薬的応用 Pending JP2024519993A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202110606803.1 2021-05-27
CN202110606803 2021-05-27
CN202110976020.2 2021-08-24
CN202110976020 2021-08-24
PCT/CN2022/095441 WO2022247920A1 (zh) 2021-05-27 2022-05-27 喹啉胺类化合物、其制备方法及其在医药上的应用

Publications (2)

Publication Number Publication Date
JP2024519993A JP2024519993A (ja) 2024-05-21
JP2024519993A5 true JP2024519993A5 (enExample) 2025-05-16

Family

ID=84228425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572661A Pending JP2024519993A (ja) 2021-05-27 2022-05-27 キノリンアミン系化合物、その調製方法及びその医薬的応用

Country Status (11)

Country Link
US (1) US20240327388A1 (enExample)
EP (1) EP4349831A4 (enExample)
JP (1) JP2024519993A (enExample)
KR (1) KR20240014059A (enExample)
CN (1) CN117222639A (enExample)
AU (1) AU2022283404A1 (enExample)
BR (1) BR112023024741A2 (enExample)
CA (1) CA3219657A1 (enExample)
MX (1) MX2023013972A (enExample)
TW (1) TW202313592A (enExample)
WO (1) WO2022247920A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025538576A (ja) * 2022-11-25 2025-11-28 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 キノリンアミン系化合物の結晶型及びその調製方法
TW202436295A (zh) * 2022-11-25 2024-09-16 大陸商江蘇恒瑞醫藥股份有限公司 喹啉胺類化合物的可藥用鹽、晶型及其製備方法
CN116854634B (zh) * 2023-06-27 2025-12-09 广东药科大学 一种选择性ces2抑制剂、其制备方法及其作为药物的用途
AU2024334442A1 (en) * 2023-08-30 2026-03-05 Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. Compound for regulating activity of microrna-124
CN120698979A (zh) * 2024-03-26 2025-09-26 深圳信立泰药业股份有限公司 一种吲哚类化合物及其制备方法与miR上调应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015645A1 (fr) * 1998-09-11 2000-03-23 Kyorin Pharmaceutical Co., Ltd. Derives d'esters phosphoniques et leur procede de production
FI2440546T3 (fi) 2009-06-12 2023-03-30 Abivax Ennenaikaisen vanhenemisen ja erityisesti progerian hoitamiseen hyödyllisiä yhdisteitä
JP2011026251A (ja) * 2009-07-27 2011-02-10 Kowa Co 2−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤
WO2012037351A1 (en) 2010-09-17 2012-03-22 Glaxosmithkline Llc Compounds
CN104109165A (zh) 2013-04-19 2014-10-22 四川海思科制药有限公司 4,5-二氢-吡唑并[3,4-c]吡啶-2-酮衍生物、其制备方法以及应用
MX382692B (es) 2013-07-05 2025-03-13 Abivax Compuestos bicíclicos útiles para el tratamiento de enfermedades causadas por retrovirus.
EP2974729A1 (en) * 2014-07-17 2016-01-20 Abivax Quinoline derivatives for use in the treatment of inflammatory diseases
EP3059236A1 (en) * 2015-02-23 2016-08-24 Abivax A new quinoline derivative for use in the treatment and prevention of viral infections
PL3429998T3 (pl) 2016-03-18 2022-03-14 Prosynergia S.à.r.l. Sposób wytwarzania pochodnych chinolin-2-ylo-fenyloaminy oraz jej soli
EP3669873A1 (en) * 2018-12-20 2020-06-24 Abivax Quinoline derivatives for use ine the traeatment of inflammation diseases
IL294705A (en) * 2020-01-24 2022-09-01 Univ Princeton Heterocyclic compounds and their uses

Similar Documents

Publication Publication Date Title
JP2021523112A5 (enExample)
JP2024522766A5 (enExample)
JP2024519188A5 (enExample)
AU2020281003A1 (en) Process for preparing an anti-cancer agent, 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts
JP2020066629A5 (enExample)
JP2018519323A5 (enExample)
JP2019518766A5 (enExample)
JP2018536705A5 (enExample)
JP2019519476A5 (enExample)
CN110573501A (zh) Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
JP2018511634A5 (enExample)
JP2016514719A5 (enExample)
JP2019507130A5 (enExample)
JP2002513035A (ja) Cox−2阻害薬の合成方法
JP2023164918A5 (enExample)
JP2020506899A5 (enExample)
JP2023509944A5 (enExample)
JP2020535124A5 (enExample)
SI3102573T1 (en) SUBSTITUTED TIAZOL OR OXASOL AS ANTAGONISTS OF THE RECEPTOR P2X7
WO2014168522A4 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
JP2021510692A5 (enExample)
JP2020511547A5 (enExample)
JP2023554081A5 (enExample)
JP2020503376A5 (enExample)
AU2022283404A1 (en) Quinolinamine compound, preparation method therefor and application thereof in pharmaceuticals